All Professionals
Overview
Youssef Aziz is an associate in the Corporate practice of Paul Hastings and is based in the firm’s New York office. Mr. Aziz has experience representing both public and private companies in a wide range of corporate transactions, including mergers and acquisitions, private equity financings, strategic transactions, securities offerings (as counsel to issuers and underwriters), SPAC and de-SPAC transactions, corporate governance and compliance, SEC periodic reporting requirements, and other general corporate matters.
Mr. Aziz is fluent in English and Arabic. Prior to joining the firm, he was an associate at the Toronto office of another international law firm.
Education
- University of Toronto Faculty of Law, J.D., 2019
- Wilfrid Laurier University, Bachelor of Business Administration (BBA), 2015
Representations
- Scilex Holding Company on its $1.64 billion go public transaction with Vickers Vantage Corp. I
- Jasper Therapeutics, Inc. in its underwritten public offering of its common stock with gross proceeds of approximately $103.5 million
- Seelos Therapeutics, Inc. in its registered direct offering of its common stock and warrants to purchase common stock with gross proceeds of approximately $11.24 million
- Paul Hastings Advised Freedom Acquisition I Corp. in Business Combination with Complete Solaria | Paul Hastings LLP
- Paul Hastings Advised Altisource Portfolio Solutions on Follow-On Public Equity Offering | Paul Hastings LLP
news
- Paul Hastings Advised FACT II Acquisition Corp. on the Pricing of Its IPO - November 26th, 2024
- Paul Hastings Advised Morgan Stanley, Goldman Sachs, HSBC, Wells Fargo Securities, and Others on Helmerich & Payne’s $1.25 Billion Senior Notes Offering - September 24th, 2024
- Paul Hastings Advised Semnur Pharmaceuticals, Inc. in $2.5 Billion SPAC Merger Agreement with Denali Capital Acquisition Corp. - September 3rd, 2024
- Paul Hastings Advised Underwriters on Super Hi International’s Public Offering and Listing on the Nasdaq Global Market - May 22nd, 2024
- Paul Hastings Advised Kyverna Therapeutics on $319 Million Upsized IPO - February 9th, 2024
- Paul Hastings Advised Goldman and J.P. Morgan as Co-Lead Underwriters in SharkNinja, Inc.’s Secondary Public Offering of Ordinary Shares - December 11th, 2023